Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

MKSAP: 38-year-old woman with a HbA1c value of 9.1%

mksap
Conditions
September 2, 2017
Share
Tweet
Share

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians.

A 38-year-old woman is evaluated after laboratory study results show an HbA1c value of 9.1%. Her HbA1c goal is less than 7% because she has high function, long life expectancy, few comorbidities, good support, health literacy, and access to care. Medical history is significant for morbid obesity, obstructive sleep apnea, hypertension, and hyperlipidemia. Family history is notable for her mother, sister, and brother with type 2 diabetes, obesity, hypertension, and hyperlipidemia. Medications are insulin glargine 110 units subcutaneous injection at bedtime (split into two injection depots), metformin (1000 mg twice daily), atenolol (100 mg daily), lisinopril (20 mg daily), hydrochlorothiazide (25 mg daily), and rosuvastatin (20 mg daily).

On physical examination she is afebrile, blood pressure is 148/79, pulse rate is 68/min, and respiration rate is 14/min. BMI is 42.1.

Laboratory studies show plasma glucose 229 mg/dL (12.7 mmol/L), HDL cholesterol 32 mg/dL (0.83 mmol/L), LDL cholesterol 92 mg/dL (2.4 mmol/L), triglycerides 247 mg/dL (2.8 mmol/L), and estimated glomerular filtration rate (eGFR) 40 mL/min/1.73 m2. Results of other laboratory studies, including electrolytes levels and liver chemistry tests, are within normal limits.

Which of the following is the most appropriate treatment for this patient?

A. Increase insulin glargine
B. Initiate fenofibrate
C. Initiate glipizide
D. Initiate liraglutide

MKSAP Answer and Critique

Correct answer: D. Initiate liraglutide.

The most appropriate treatment for this patient is to initiate liraglutide. Liraglutide is a synthetic glucagon-like peptide-1 receptor agonist (GLP-1 agonist) that stimulates glucose-dependent insulin release from the pancreatic islets. It has been shown to decrease HbA1c by up to 1.5% as monotherapy, with relatively low risk of hypoglycemia. A recent study published in Diabetes, Obesity and Metabolism investigated the efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes mellitus. This randomized, double-blind parallel group study showed that in overweight and obese adults from more than 75 sites in North and South America, Europe, and Asia, the addition of liraglutide to a basal insulin regimen that also included metformin in some participants resulted in a significant decrease in HbA1c levels compared with placebo. The authors also showed that body weight and systolic blood pressure significantly decreased in the liraglutide-treated participants (−3 kg and −5 mm Hg, respectively). All three of these outcomes are relevant to this patient who is morbidly obese with an HbA1c level above goal and blood pressure above goal. In the aforementioned study, insulin doses were decreased by 20% at randomization to decrease the risk of hypoglycemia; no severe hypoglycemia (defined in this study as a glucose <56 mg/dL [3.1 mmol/L]) was reported, but there was an increase in minor hypoglycemia in the liraglutide group. When initiating liraglutide in patients already taking insulin, a decrease in insulin dosing should be considered. A thorough neck examination should also be performed to screen for thyroid nodules, as liraglutide has been associated with C-cell tumors of the thyroid, including medullary thyroid cancer; in patients with a personal or family history of medullary thyroid cancer, its use is contraindicated.

The insulin glargine dose should not be increased because the patient’s dose is 110 units, which is more than 1 U/kg/d. If more insulin is required, prandial insulin is safer and more effective. Typically, total daily insulin doses are 50% basal insulin and 50% prandial insulin (split between meals). Increasing her basal insulin dose will increase her risk of hypoglycemia if she misses or is late eating a meal, or if she sleeps late.

Fenofibrate should not be initiated because her triglyceride level of 247 mg/dL (2.8 mmol/L), while elevated, is not high enough to incur a risk of pancreatitis, and the most pressing clinical concern in this patient is getting her HbA1c level to goal to lower her risks of macro- and microvascular complications of diabetes.

Glipizide should not be initiated because in a patient already on high dose insulin with an HbA1c level above 9%, a secretagogue will not offer additional glucose lowering. Her endogenous production of insulin is at its maximum rate, given her estimated average glucose of 215 mg/dL (11.9 mmol/L) (correlates to an HbA1c level of 9.1%).

Key Point

  • In a recent clinical trial, liraglutide, in addition to a basal insulin analogue with or without metformin, significantly improved glycemic control, body weight, and systolic blood pressure compared with placebo.

This content is excerpted from MKSAP 17 with permission from the American College of Physicians (ACP). Use is restricted in the same manner as that defined in the MKSAP 16 Digital license agreement. This material should never be used as a substitute for clinical judgment and does not represent an official position of ACP. All content is licensed to KevinMD.com on an “AS IS” basis without any warranty of any nature. The publisher, ACP, shall not be liable for any damage or loss of any kind arising out of or resulting from use of content, regardless of whether such liability is based in tort, contract or otherwise.

Prev

Patients and doctors should give each other the benefit of the doubt

September 1, 2017 Kevin 0
…
Next

Stories to help parents think critically about the importance of vaccinations

September 2, 2017 Kevin 2
…

ADVERTISEMENT

Tagged as: Diabetes, Endocrinology, Primary Care

Post navigation

< Previous Post
Patients and doctors should give each other the benefit of the doubt
Next Post >
Stories to help parents think critically about the importance of vaccinations

ADVERTISEMENT

More by mksap

  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 26-year-old man with back pain

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 36-year-old man with abdominal cramping, diarrhea, malaise, and nausea

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 52-year-old woman with osteoarthritis of the right hip

    mksap

Related Posts

  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 45-year-old woman with type 2 diabetes mellitus

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 35-year-old woman with constipation

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 60-year-old woman with persistent constipation

    mksap
  • 3 ways we’ve failed woman who breastfeed

    Joanna Buscemi, PhD
  • How one woman prevented a pharmaceutical disaster

    James Essinger and Sandra Koutzenko
  • A skin-lightening cream put a woman into a coma. How can that happen?

    Anna Almendrala

More in Conditions

  • Why your clinic waiting room may affect patient outcomes

    Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT
  • The ethical crossroads of medicine and legislation

    M. Bennet Broner, PhD
  • When doctors breathe the same air: How medical professionals become environmental activists

    Stephen Gitonga
  • When doctors don’t talk: a silent failure in modern medicine

    Cesar Querimit, Jr.
  • The many faces of physician grief

    Annia Raja, PhD
  • How early care saved my life from silent kidney disease

    Charlie Cloninger
  • Most Popular

  • Past Week

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Why your clinic waiting room may affect patient outcomes

      Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT | Conditions
    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • The backbone of health care is breaking

      Grace Yu, MD | Physician
    • Why transplant equity requires more than access

      Zamra Amjid, DHSc, MHA | Policy
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Why retail pharmacies could transform diversity in clinical trials [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why your clinic waiting room may affect patient outcomes

      Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT | Conditions
    • Food is a universal language in medicine

      Diego R. Hijano, MD | Physician
    • The ethical crossroads of medicine and legislation

      M. Bennet Broner, PhD | Conditions
    • When doctors breathe the same air: How medical professionals become environmental activists

      Stephen Gitonga | Conditions
    • Why vitamins should be part of the mental health conversation [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • Why your clinic waiting room may affect patient outcomes

      Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT | Conditions
    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • The backbone of health care is breaking

      Grace Yu, MD | Physician
    • Why transplant equity requires more than access

      Zamra Amjid, DHSc, MHA | Policy
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Why retail pharmacies could transform diversity in clinical trials [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why your clinic waiting room may affect patient outcomes

      Ziya Altug, PT, DPT and Shirish Sachdeva, PT, DPT | Conditions
    • Food is a universal language in medicine

      Diego R. Hijano, MD | Physician
    • The ethical crossroads of medicine and legislation

      M. Bennet Broner, PhD | Conditions
    • When doctors breathe the same air: How medical professionals become environmental activists

      Stephen Gitonga | Conditions
    • Why vitamins should be part of the mental health conversation [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...